Jiangsu Bioperfectus Technologies (688399.SH) Obtains Two Medical Device Registration Certificates

Stock News
Sep 29, 2025

Jiangsu Bioperfectus Technologies Co.,Ltd. (688399.SH) announced that the company has recently received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products Administration. The approved products include the Adenovirus Antigen Detection Kit (Colloidal Gold Method) and the Seven Respiratory Pathogen Nucleic Acid Detection Kit (Fluorescent PCR Method). The acquisition of these Medical Device Registration Certificates enriches the company's product portfolio, expands its presence in the in vitro diagnostics sector, and continuously meets diversified clinical demands. This development will strengthen the company's comprehensive competitiveness and facilitate further enhancement of its market expansion capabilities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10